Prothena Corp. | Key People and Executives
Gene G. Kinney
President, Chief Executive Officer & Director
Karl Anders Olof Härfstrand
Independent Director
Dennis J. Selkoe
Independent Director
Christopher S. Henney
Independent Director
Shane M. Cooke
Independent Director
Richard T. Collier
Independent Director
Gene G. Kinney
President, Chief Executive Officer & Director
Tran B. Nguyen
Chief Operating & Financial Officer
Wagner Zago
Chief Scientific Officer
Matt Panuwat
Vice President-Business Development
Tara Nickerson
Chief Business Officer
Karin L. Walker
Chief Accounting Officer & Controller
Ellen Rose
Head-Communications & Media Relations
Yvonne M. Tchrakian
Secretary
Carol D. Karp
Chief Regulatory Officer
Arthur William Homan
Chief Legal Officer
Karl Anders Olof Härfstrand
Independent Director
Dennis J. Selkoe
Independent Director
Christopher S. Henney
Independent Director
Shane M. Cooke
Independent Director
Richard T. Collier
Independent Director
Address |
77 Sir John Rogersons Quay Dun Laoghaire Dublin 2 Ireland
|
Employees
|
- |
Website |
http://www.prothena.com |
Updated |
07/08/2019 |
Prothena Corp. Plc is a late-stage clinical biotechnology company, which research, development and commercialization of therapies in the neuroscience and orphan categories. Its antibody-based product candidates target a potential indications including amyloidosis and Parkinson's disease. The company was founded on December 20, 2012 and is headquartered in Dun Laoghaire, Ireland. |